David Shaw’s Zymergen Inc. Common Stock ZY Stock Holding History

David Shaw’s Portfolio ZY Stock Details ZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-96,685	Closed	-$269K	–	5558
2022 Q3	$269K	Sell	96,685 -962,595	-91%	-$2.34M	﹤0.01%	4348
2022 Q2	$1.3M	Buy	1,059,280 +11,115	+1%	+$18.6K	﹤0.01%	3448
2022 Q1	$3.03M	Buy	1,048,165 +285,914	+38%	+$1.21M	﹤0.01%	2876
2021 Q4	$5.1M	Buy	762,251 +750,835	+6,577%	+$7.29M	﹤0.01%	2351
2021 Q3	$150K	Buy	+11,416	New	+$242K	﹤0.01%	4636

David Shaw's ZY Position: Q4 2022 in Review

David Shaw sold out of Zymergen Inc. Common Stock (ZY) in Q4 2022, closing a stake of 96,685 shares — an estimated $269K sold.

David Shaw first reported a position in ZY in Q3 2021 and held it in 5 quarters. The position peaked at $5.1M in Q4 2021. 0 funds tracked by Wall St. Rank hold ZY as of Q4 2022.

David Shaw reported no remaining Zymergen Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
David Shaw sold 96,685 Zymergen Inc. Common Stock shares in Q4 2022, an estimated $269K.
David Shaw first reported a position in Zymergen Inc. Common Stock in Q3 2021 and held it in 5 quarters.
David Shaw's Zymergen Inc. Common Stock position peaked at $5.1M in Q4 2021.
0 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q4 2022.

Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.